Skip to main content
Anoro Ellipta 62.5 ug/1, 25 ug/1 powder by GlaxoSmithKline LLC
Anoro Ellipta, 62.5 ug/1, 25 ug/1, powder Drug class: Anticholinergic; beta2-Adrenergic Agonist. Available on prescription only. Listed by GlaxoSmithKline LLC.
Prescription only

Anoro Ellipta

umeclidinium bromide and vilanterol trifenatate

Listed by GlaxoSmithKline LLC

Strength
62.5 ug/1, 25 ug/1
Form
Powder
Route
Respiratory (inhalation)
Class
Anticholinergic; beta2-Adrenergic Agonist

What it contains

  • Umeclidinium Bromide 62.5 ug/1
  • Vilanterol Trifenatate 25 ug/1

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Powder
Route Respiratory (inhalation)
Drug class Anticholinergic; beta2-Adrenergic Agonist
Approval route NDA — original brand approval
NDC code 0173-0869
FDA application NDA203975
RxNorm concept 1487519
Package sizes listed 2
Marketed since January 2014

Other products containing Umeclidinium Bromide

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Incruse Ellipta

umeclidinium

Strength
62.5 ug/1
Form
Aerosol, Powder
Class
Anticholinergic
Rx only

GlaxoSmithKline LLC

Not stocked by us — reference only

Umeclidinium and Vilanterol Ellipta

umeclidinium bromide and vilanterol trifenatate

Strength
62.5 ug/1, 25 ug/1
Form
Powder
Class
Anticholinergic; beta2-Adrenergic Agoni…
Rx only

Prasco Laboratories

Not stocked by us — reference only

Umeclidinium Ellipta

umeclidinium

Strength
62.5 ug/1
Form
Aerosol, Powder
Class
Anticholinergic
Rx only

Prasco Laboratories

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.